Epidemiology of AIDS dementia complex in Europe

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 11, Issue 1, 1996, Pages 39-44

  Chiesi, A ^a   Vella, S ^a   Dally, L G ^a   Pedersen, C ^b   Danner, S ^c   Johnson, A M ^d   Schwander, S ^e   Goebel, F D ^f   Glauser, M ^g   Antunes, F ^h   Lundgren, J D ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b HVIDOVRE HOSPITAL   (Denmark)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^h HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

AIDS dementia complex; Epidemiology in Europe; Prophylaxis; Zidovudine

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DEMENTIA; DRUG EFFECT; EUROPE; FEMALE; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 1542744960     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199601010-00005     Document Type: Article

References (20)

1. Working Group of the American Academy of Neurology AIDS Task Force, Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 1991;41: 778-85.
2. Navia BA, Barry DJ, Price RW. The AIDS dementia complex. I. Clinical features. Ann Neurol 1986a;19:517-24.
3. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1988;158:1079-83.
4. Price RW, Brew B, Sidtis J, et al. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988;239:586-92.
5. Levy RM, Janssen RS, Bush TJ, Rosenblum ML. Neuroep- : idemiology of acquired immunodeficiency syndrome. In: Rosenblum ML, Levy RM, Bredesen DE, eds. AIDS and the nervous system. New York: Raven Press, 1988:13-7.
6. Levy RM, Bredesen DE. Central nervous system dysfunction in acquired immunodeficiency syndrome. In: Rosenblum ML, Levy RM, Bredesen DE, eds. AIDS and the nervous system. New York: Raven Press, 1988:29-63.
7. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36:1S-14S.
8. Yarchoan R, Berg G, Brouwers P, et al. Response of human-immunodeficiency-virus-associated neurological disease to 3′-azido-3′-deoxythymidine. Lancet 1987;1:132-5.
9. Portegies P, De Gans J, Lange JMA, et al. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. Br Med J 1989;299:819-21.
10. Portegies P, Henting RH, De Gans J, et al. Presentation and course of AIDS dementia complex: 10 years of follow up in Amsterdam, The Netherlands. AIDS 1993;7:669-75.
11. Gray F, Belec L, Keohane C, et al. Zidovudine tjeraphy and HIV encephalitis: a 10-year neuropathological survey. AIDS 1994;8:489-93.
12. Lundgren JD, Pedersen C, Clumeck N, et al. Survival differences in European patients with AIDS, 1979-89. Br Med J 1994;308:1068-73.
13. Lundgren JD, Philips AN, Pedersen C, et al. Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. JAMA 1994;14:1088-92.
14. Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 1992;42:1472-6.
15. Chiesi A, Dally LG, Zaccarelli M, et al. Incidence of AIDS dementia complex at onset of AIDS is greater for IVDUs. A study on 8197 cases diagnosed in Italy between August 1987 and March 1991 [Abstract]. Presented at the III European Conference on Clinical Aspects and Treatment of HIV infection, Paris, 1992.
16. Greenberg AE, Thomas PA, Landesman SH, et al. The spectrum of HIV-1-related disease among outpatients in New York City. AIDS 1992;6:849-59.
17. Chiesi A, Dally LG, D'Alessandro M, et al. Factors influencing neuropsychological performance in HIV infected individuals [Abstract], Presented at the IXth International Conference on AIDS, Berlin, 1993.
18. Concorde Coordinating Committee. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 1994;343:871-80.
19. Volberding PA, Lagakos SW, Grimes JM, et al. The duration of zidovudine benefit in persons with asymptomatic HIV infection: prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group. JAMA 1994;272:437-42.
20. Elovaara I, Poutiainen E, Lahdevirta J, et al. Zidovudine reduces intrathecal immunoactivation in patients with early human immunodeficiency virus type 1 infection. Arch Neurol 1994;51:943-50.